These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3373589)

  • 41. Adjuvant methotrexate, vinblastine and cisplatin chemotherapy for invasive transitional cell carcinoma: Taiwan experience.
    Wei CH; Hsieh RK; Chiou TJ; Chen KK; Chang LS; Chen PM
    J Urol; 1996 Jan; 155(1):118-21. PubMed ID: 7490806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radical cystectomy and adjuvant chemotherapy.
    Hill DE; Ford KS; Soloway MS
    Urology; 1985 Feb; 25(2):151-4. PubMed ID: 4038565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Multi-Institutional Analysis of Outcomes of Patients with Clinically Node Positive Urothelial Bladder Cancer Treated with Induction Chemotherapy and Radical Cystectomy.
    Zargar-Shoshtari K; Zargar H; Lotan Y; Shah JB; van Rhijn BW; Daneshmand S; Spiess PE; Black PC
    J Urol; 2016 Jan; 195(1):53-9. PubMed ID: 26205531
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Postoperative systemic adjuvant chemotherapy for bladder cancer.
    Kiyohara H; Kuroda M; Saiki S; Miki T; Kinouchi T; Usami M; Kotake T
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S34-8. PubMed ID: 3664942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors.
    Angulo JC; Sanchez-Chapado M; Lopez JI; Flores N
    J Urol; 1996 Jun; 155(6):1897-902. PubMed ID: 8618282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience.
    Fair WR; Scher H; Herr H; Morse M; Sogani P; Bosi G; Dershaw D; Reuter V; Curley T
    Semin Urol; 1990 Aug; 8(3):190-6. PubMed ID: 2399387
    [No Abstract]   [Full Text] [Related]  

  • 47. The role of surveillance in the treatment of patients with muscle-invasive bladder cancer after chemotherapy.
    Hellenthal NJ; Ramirez ML; Evans CP; Devere White RW
    BJU Int; 2010 Feb; 105(4):485-8. PubMed ID: 19849694
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase III comparison of cisplatin alone versus cisplatin, doxorubicin and cyclophosphamide in the treatment of bladder (urothelial) cancer: a Southeastern Cancer Study Group trial.
    Troner M; Birch R; Omura GA; Williams S
    J Urol; 1987 Apr; 137(4):660-2. PubMed ID: 3550148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A pilot study of chemotherapy alternating with twice-a-day accelerated radiation therapy as an alternative to cystectomy in muscle infiltrating (stages T2 and T3) cancer of the bladder: preliminary results.
    Vikram B; Malamud S; Silverman P; Hecht H; Grabstald H
    J Urol; 1994 Mar; 151(3):602-4. PubMed ID: 8308967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan.
    Matsui Y; Nishiyama H; Watanabe J; Teramukai S; Ono Y; Ohshima S; Fujimoto K; Hirao Y; Fukushima M; Ogawa O
    Int J Clin Oncol; 2005 Apr; 10(2):133-8. PubMed ID: 15864700
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preliminary results in invasive bladder cancer with transurethral resection, neoadjuvant chemotherapy and combined pelvic irradiation plus cisplatin chemotherapy.
    Prout GR; Shipley WU; Kaufman DS; Heney NM; Griffin PP; Althausen AF; Bassil B; Nocks BN; Parkhurst EC; Young HH
    J Urol; 1990 Nov; 144(5):1128-34; discussion 1134-6. PubMed ID: 2122007
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial.
    Studer UE; Bacchi M; Biedermann C; Jaeger P; Kraft R; Mazzucchelli L; Markwalder R; Senn E; Sonntag RW
    J Urol; 1994 Jul; 152(1):81-4. PubMed ID: 8201695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transurethral resection in regionally advanced bladder cancer.
    Herr HW
    Urol Clin North Am; 1992 Nov; 19(4):695-700. PubMed ID: 1441026
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
    Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
    Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy.
    Inoue K; Slaton JW; Karashima T; Yoshikawa C; Shuin T; Sweeney P; Millikan R; Dinney CP
    Clin Cancer Res; 2000 Dec; 6(12):4866-73. PubMed ID: 11156246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bladder-sparing approach in the treatment of invasive bladder cancer.
    Wajsman Z; Marino R; Parsons J; Oblon D; McCarley D
    Semin Urol; 1990 Aug; 8(3):210-5. PubMed ID: 2119051
    [No Abstract]   [Full Text] [Related]  

  • 57. Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer.
    Raj GV; Karavadia S; Schlomer B; Arriaga Y; Lotan Y; Sagalowsky A; Frenkel E
    Cancer; 2011 Jan; 117(2):276-82. PubMed ID: 20830767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Adjuvant polychemotherapy after radical cystectomy of metastatic bladder cancer].
    Stöckle M
    Urologe A; 1994 Nov; 33(6):568-75. PubMed ID: 7817458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extended experience of neo-adjuvant M-VAC chemotherapy for T1-4 N0 M0 transitional cell carcinoma of the urinary bladder.
    Keating JP; Zincke H; Hahn RG; Morgan WR
    Prog Clin Biol Res; 1990; 353():119-27. PubMed ID: 2217409
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparing intra-arterial chemotherapy combined with intravesical chemotherapy versus intravesical chemotherapy alone: a randomised prospective pilot study for T1G3 bladder transitional cell carcinoma after bladder-preserving surgery.
    Chen J; Yao Z; Qiu S; Chen L; Wang Y; Yang J; Li J
    Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1521-1526. PubMed ID: 23511989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.